Aug 25, 2026 earnings call — Driving cash flow; Healthcare Services reaches profitability inflection
SelectQuote expects operating cash flow to approximately double to $60 million plus in fiscal 2027.
Revenue $0.3B (est $0.4B) · EPS $-0.19 (est $-0.17) · Next-quarter revenue outlook $1.4B–$1.4B
Key quotes
"SelectQuote's highest priority continues to be driving profitable cash flow, and our fiscal 2026 results demonstrate meaningful progress against that objective."
"SelectRx continued to prove the earnings power of its scaled membership base, producing approximately $25 million of adjusted EBITDA for the year, while exiting at nearly $50 million annual run rate in the fourth quarter."
"In this facility, we are already recognizing around 30% efficiency gains on shipments relative to our two legacy locations."
Analyst Q&A 4
Grow healthcare membership beyond seniors
Q (Benjamin Hendrix · RBC): He asked if Healthcare Services can grow membership outside the Senior business and if there are other opportunities given softer Medicare Advantage trends. He also asked about the Kansas City facility penetration and target margins once fully integrated.
A: Management said Healthcare Services is gaining momentum but remains synergistic with the Senior platform, so the Senior pullback will affect healthcare. They are focused on operational efficiencies and new technology, including AI, to help prove a doubling of margins. Kansas City is about 30% more efficient and will handle a large share of enrollments; long-term target is low double-digit EBITDA margins.
"Over the long term, we are still expecting low double-digit EBITDA margins." — Ryan Clement (CFO)
Medicare Advantage market and IRA drug effects
Q (George Sutton · Craig-Hallum): He asked for an update on carrier messaging and whether SLQT can maintain upside if the MA market turns. He also asked how the Inflation Reduction Act affected Rx pricing and customer mix profitability.
A: Management said the MA market is healing but payers still have elevated MLRs and are targeting 3% to 4% operating margins, so discipline and some market disruption can continue. On the IRA, they said it pushed down consumer costs but increased payer pressure and introduced coinsurance for drugs, which has put top-line pressure while margins are less affected; rebates flow through cost of goods and 2027 will show more top-line headwinds.
"Their MLRs are still elevated relative to historical norms, maybe better than forecast, but higher than historical." — Timothy Danker (CEO)
Cash flow drivers and Senior conversion rates
Q (Steven Couche · Jefferies): He asked whether the roughly $40 million delta between EBITDA and operating cash flow improvement was mainly from slower Senior growth or other factors. He also asked if Healthcare Services membership will be flat and why Senior conversion rates exceeded 100% and whether they will stay high.
A: Management said the primary driver of improved cash flow is progression in Healthcare Services as margins expand, helped by Kansas City pharmacy, a pharmacy management system, and AI that should save about $30 million. They expect Healthcare Services membership to be roughly flat at the end of fiscal 2027 despite the Senior pullback. on conversion rates, they said higher close rates reflect core agents handling more leads and approvals trickling in after OEP, and they expect conversion rates to remain high.
"No. I mean the primary drivers of the improved cash flow is continued progression in Healthcare Services as we expect those margins to expand." — Ryan Clement (CFO)
Commissions receivable and capital allocation
Q (Michael Kupinski · NOBLE Capital Markets,): He asked how much 2027 cash generation will come from the existing $1 billion commissions receivable book and asked for a framework for cash generation over the next 3–5 years. He also asked if securitization thinking changed and how they will allocate cash between delevering, preferreds, reinvestment, and returning capital.
A: Management said operating cash flow should exceed $60 million in 2027 and the billion-dollar commissions receivable balance is expected to be relatively flat as they write new policies and collect existing receivables. Securitization remains an available path but short-term probability is relatively low given Medicare market dynamics. They said delevering and high-ROI reinvestments are top priorities, and they intend to cash pay PIK in the future though dollars are not yet earmarked.
"Expect to build upon that in 2027 with operating cash flow exceeding $60 million." — Ryan Clement (CFO)